Correction: LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation

被引:0
|
作者
Kaixuan Zeng
Xiaoxiang Chen
Xiuxiu Hu
Xiangxiang Liu
Tao Xu
Huiling Sun
Yuqin Pan
Bangshun He
Shukui Wang
机构
[1] Southeast University,School of Medicine
[2] Nanjing Medical University,General Clinical Research Center, Nanjing First Hospital
来源
Oncogene | 2021年 / 40卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3772 / 3773
页数:1
相关论文
共 50 条
  • [1] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
    Kaixuan Zeng
    Xiaoxiang Chen
    Xiuxiu Hu
    Xiangxiang Liu
    Tao Xu
    Huiling Sun
    Yuqin Pan
    Bangshun He
    Shukui Wang
    [J]. Oncogene, 2018, 37 : 5534 - 5551
  • [2] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
    Zeng, Kaixuan
    Chen, Xiaoxiang
    Hu, Xiuxiu
    Liu, Xiangxiang
    Xu, Tao
    Sun, Huiling
    Pan, Yuqin
    He, Bangshun
    Wang, Shukui
    [J]. ONCOGENE, 2018, 37 (41) : 5534 - 5551
  • [3] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation (vol 37, pg 5534, 2018)
    Zeng, Kaixuan
    Chen, Xiaoxiang
    Hu, Xiuxiu
    Liu, Xiangxiang
    Xu, Tao
    Sun, Huiling
    Pan, Yuqin
    He, Bangshun
    Wang, Shukui
    [J]. ONCOGENE, 2021, 40 (21) : 3772 - 3773
  • [4] TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation
    Bae, Seunghee
    Jung, Jin Hyuk
    Kim, Karam
    An, In-Sook
    Kim, Soo-Yeon
    Lee, Jae Ho
    Park, In-Chul
    Jin, Young-Woo
    Lee, Su-Jae
    An, Sungkwan
    [J]. FEBS LETTERS, 2012, 586 (19) : 3057 - 3063
  • [5] XPC promotes MDM2-mediated degradation of the p53 tumor suppressor
    Krzeszinski, Jing Yan
    Choe, Vitnary
    Shao, Jia
    Bao, Xin
    Cheng, Haili
    Luo, Shiwen
    Huo, Keke
    Rao, Hai
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2014, 25 (02) : 213 - 221
  • [6] ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
    Ning, Yichong
    Hui, Na
    Qing, Bei
    Zhuo, Yiming
    Sun, Wei
    Du, Yan
    Liu, Shunlian
    Liu, Kaili
    Zhou, Jianlin
    [J]. CELL DEATH & DISEASE, 2019, 10 (6)
  • [7] ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
    Yichong Ning
    Na Hui
    Bei Qing
    Yiming Zhuo
    Wei Sun
    Yan Du
    Shunlian Liu
    Kaili Liu
    Jianlin Zhou
    [J]. Cell Death & Disease, 10
  • [8] Akt enhances Mdm2-mediated ubiquitination and degradation of p53
    Ogawara, Y
    Kishishita, S
    Obata, T
    Isazawa, Y
    Suzuki, T
    Tanaka, K
    Masuyama, N
    Gotoh, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21843 - 21850
  • [9] HADHA promotes glioma progression by accelerating MDM2-mediated p53 ubiquitination
    Chen, Rudong
    Chen, Hao
    Hu, Changchen
    [J]. CANCER GENE THERAPY, 2024,
  • [10] Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination
    O'Keefe, K
    Li, HP
    Zhang, YP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (18) : 6396 - 6405